Waddell & Reed Financial’s Moderna MRNA Stock Holding History

Waddell & Reed Financial’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$275M	Sell	2,096,747 -1,114	-0.1%	-$161K	0.56%	38
2020 Q4	$219M	Sell	2,097,861 -398,973	-16%	-$40.4M	0.46%	47
2020 Q3	$177M	Sell	2,496,834 -8,855	-0.4%	-$617K	0.42%	55
2020 Q2	$161M	Buy	2,505,689 +200,010	+9%	+$11M	0.42%	60
2020 Q1	$69.1M	Buy	2,305,679 +600,000	+35%	+$13.8M	0.22%	123
2019 Q4	$33.4M	Sell	1,705,679 -33,854	-2%	-$601K	0.08%	260
2019 Q3	$27.7M	Buy	1,739,533 +11,191	+0.6%	+$165K	0.07%	284
2019 Q2	$25.3M	Hold	1,728,342	–	–	0.06%	305
2019 Q1	$35.2M	Buy	1,728,342 +228,342	+15%	+$4.24M	0.09%	270
2018 Q4	$22.9M	Buy	+1,500,000	New	+$24.7M	0.06%	307

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Waddell & Reed Financial's MRNA Position: Q1 2021 in Review

Waddell & Reed Financial reduced its Moderna (MRNA) stake by 0.05% in Q1 2021, selling an estimated $161K and leaving 2,096,747 shares worth $275M. The position accounts for 0.56% of the portfolio, ranked #38.

Waddell & Reed Financial first reported a position in MRNA in Q4 2018 and has held it in 10 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

Waddell & Reed Financial held 2,096,747 shares of Moderna worth $275M as of Q1 2021.
Waddell & Reed Financial sold 1,114 Moderna shares in Q1 2021, an estimated $161K.
Moderna made up 0.56% of Waddell & Reed Financial's portfolio in Q1 2021, its #38 holding.
Waddell & Reed Financial first reported a position in Moderna in Q4 2018 and has held it in 10 quarters since.
777 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.